Editas MedicineRecent Data Breaches and Security Report

https://editasmedicine.com  ᛫ 
Last updated October 26, 2018

Company Details

Company Overview

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. It was founded in 2013 with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures and licensed CRISPR patents from the Broad Institute's Feng Zhang, patents from Harvard's David Liu and George Church and patents from Partners Healthcare-MGH's J. Keith Joung.

Valuation

Employees

CEO

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Editas Medicine

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Editas Medicine

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.